KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Cash from Financing Activities (2016 - 2026)

Medtronic's Cash from Financing Activities history spans 13 years, with the latest figure at -$2.1 billion for Q1 2026.

  • For Q1 2026, Cash from Financing Activities fell 19.05% year-over-year to -$2.1 billion; the TTM value through Jan 2026 reached -$5.2 billion, up 3.18%, while the annual FY2025 figure was -$4.4 billion, 2.0% up from the prior year.
  • Cash from Financing Activities for Q1 2026 was -$2.1 billion at Medtronic, down from -$395.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $3.0 billion in Q4 2022 and bottomed at -$4.9 billion in Q2 2023.
  • The 5-year median for Cash from Financing Activities is -$1.3 billion (2025), against an average of -$1.2 billion.
  • The largest annual shift saw Cash from Financing Activities surged 360.95% in 2022 before it tumbled 493.33% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $3.0 billion in 2022, then crashed by 102.99% to -$90.0 million in 2023, then crashed by 493.33% to -$534.0 million in 2024, then rose by 26.03% to -$395.0 million in 2025, then plummeted by 428.35% to -$2.1 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Cash from Financing Activities are -$2.1 billion (Q1 2026), -$395.0 million (Q4 2025), and -$1.4 billion (Q3 2025).